China Economic ReviewPharma multinational GlaxoSmithKline (GSK.NYSE, GSK.LON) appointed a senior figure from within the company as head of China operations amid a probe into corrupt practices at the company, The Wall Street Journal reported. Herve Gisserot, co-head of the British drug maker’s pharmaceutical business in Europe, is replacing Mark Reilly as general manager in China. Reilly remains […]
Beijing will discipline 39 hospital workers that took illegal kickbacks as China’s crackdown on pharmaceutical and health care misconduct continues, Bloomberg reported, citing a Tuesday report by state-backed Xinhua News Agency. The hospital staff allegedly received US$460,000 in illegal kickbacks from two pharmaceutical companies between January 2010 and December 2012, according to the National Health […]
An American citizen and two Chinese employees of drugmaker AstraZeneca (AZN.NYSE, AZN.LON) were detained by Chinese police in connection with the ongoing investigation of bribery by foreign pharma companies in China, The Guardian reported. The US embassy did not identify the American in detention or the company he works for. GlaxoSmithKline (GSK.NYSE, GSK.LON), a major focus […]
Pharma multinational GlaxoSmithKline (GSK.NYSE, GSK.LON) conceded that some of its executives in China may have broken the law, Reuters reported. In a statement, GSK said that certain senior executives had acted outside of its processes and that GSK had “zero tolerance” for such practices. The company pledged to reform its local business model to lower […]
British national Peter Humphrey, founder of the Hong Kong-based ChinaWhys investigation firm, has been detained by Shanghai police, The Wall Street Journal reported, citing people familiar with the matter. Sources said one of Humphrey’s clients was GlaxoSmithKline (GSK.NYSE, GSK.LON), which is under investigation in China for alleged bribery and related charges. Those who have worked with Humphrey […]